Dev Prasad

Stock Analyst at LUCID CAPITAL MARKETS

(n/a)
# 4,669
Out of 4,829 analysts
3
Total ratings
n/a
Success rate
-48.75%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Dev Prasad

Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $4.06
Upside: +491.13%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $0.77
Upside: +675.90%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $2.00
Upside: +550.00%